Study outcome
­­­The primary outcome was IA success and ablation applications. Secondary outcomes included immediate success, periprocedural complications, and VA recurrence. Clinical PVC frequency more than 10% of baseline or any episode of VT documented by 24-hours Holter was termed VA recurrence.12 An independent events committee judged all adverse events and their relation to ablation.